Bon Natural Life Limited (BON) 10-Year Financial Performance & Capital Metrics

BON • • Industrial / General

Consumer DefensivePackaged FoodsNutritional Supplements & WellnessHerbal & Natural Health Products

AboutBon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.Show more

Revenue $24M -19.2%
EBITDA $3M -55.6%
Net Income $398K -91.3%
EPS (Diluted) 0.17 -99.9%
Gross Margin 29.82% -0.4%
EBITDA Margin 13.21% -45.1%
Operating Margin 7.86% -60.8%
Net Margin 1.67% -89.3%
ROE 0.99% -92.9%
ROIC 3.07% -74.2%
Debt/Equity 0.16 +43.8%
Interest Coverage 6.18 -75.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Healthy 5Y average net margin of 14.5%
✓Trading at only 0.1x book value

✗Weaknesses

✗Profits declining 31.2% over 5 years
✗Weak Piotroski F-Score: 1/9
✗Negative free cash flow
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y7.78%

3Y-2.21%

TTM-18.47%

Profit (Net Income) CAGR

10Y-

5Y-31.15%

3Y-55.73%

TTM-71.39%

EPS CAGR

10Y-

5Y-49.11%

3Y-90%

TTM-74.09%

ROCE

10Y Avg20.96%

5Y Avg20.16%

3Y Avg14.69%

Latest4.55%

Peer Comparison

Herbal & Natural Health Products

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NATRNature's Sunshine Products, Inc.	396.1M	22.64	56.60	2.03%	3.18%	9.05%	3.62%	0.09
BONBon Natural Life Limited	10.59M	1.74	10.24	-19.23%	6.45%	5.65%		0.16
PAVSParanovus Entertainment Technology Ltd.	1.34M	2.01	-25.77	-98.91%	-272.35%	-62.13%		0.08

Profit & Loss

	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Sales/Revenue+	10.78M	16.4M	18.22M	25.49M	29.91M	29.52M	23.84M
Revenue Growth %	-	0.52%	0.11%	0.4%	0.17%	-0.01%	-0.19%
Cost of Goods Sold+	8.41M	11.11M	13.02M	18.38M	20.48M	20.68M	16.73M
COGS % of Revenue	0.78%	0.68%	0.71%	0.72%	0.68%	0.7%	0.7%
Gross Profit+	2.37M	5.28M	5.2M	7.11M	9.42M	8.84M	7.11M
Gross Margin %	0.22%	0.32%	0.29%	0.28%	0.32%	0.3%	0.3%
Gross Profit Growth %	-	1.23%	-0.02%	0.37%	0.33%	-0.06%	-0.2%
Operating Expenses+	1.7M	1.97M	1.37M	1.71M	2.88M	2.92M	5.24M
OpEx % of Revenue	0.16%	0.12%	0.08%	0.07%	0.1%	0.1%	0.22%
Selling, General & Admin	1.21M	1.58M	1.53M	1.46M	2.46M	2.62M	3.62M
SG&A % of Revenue	0.11%	0.1%	0.08%	0.06%	0.08%	0.09%	0.15%
Research & Development	556.09K	522.87K	205.36K	249.05K	424.56K	298.47K	1.62M
R&D % of Revenue	0.05%	0.03%	0.01%	0.01%	0.01%	0.01%	0.07%
Other Operating Expenses	0	0	-362.19K	0	0	0	0
Operating Income+	602.14K	3.18M	3.47M	5.4M	6.54M	5.92M	1.87M
Operating Margin %	0.06%	0.19%	0.19%	0.21%	0.22%	0.2%	0.08%
Operating Income Growth %	-	4.27%	0.09%	0.56%	0.21%	-0.1%	-0.68%
EBITDA+	826.23K	3.4M	3.7M	5.69M	6.91M	7.1M	3.15M
EBITDA Margin %	0.08%	0.21%	0.2%	0.22%	0.23%	0.24%	0.13%
EBITDA Growth %	-	3.12%	0.09%	0.54%	0.21%	0.03%	-0.56%
D&A (Non-Cash Add-back)	224.08K	226.63K	230.6K	286.69K	369.5K	1.18M	1.28M
EBIT	692.12K	3.32M	3.47M	5.85M	7.96M	5.79M	1.02M
Net Interest Income+	-285.22K	-330.92K	-328.39K	-414.06K	-445.49K	-228.81K	-302.86K
Interest Income	1.24K	2.27K	714	3.21K	1.39K	9.42K	393
Interest Expense	286.46K	333.19K	329.1K	417.27K	446.88K	238.22K	303.25K
Other Income/Expense	-196.49K	-185.34K	186.41K	29.76K	969.23K	-363.66K	-1.16M
Pretax Income+	405.65K	2.99M	3.65M	5.43M	7.51M	5.55M	715.94K
Pretax Margin %	0.04%	0.18%	0.2%	0.21%	0.25%	0.19%	0.03%
Income Tax+	182.28K	427.19K	556.26K	820.93K	1.27M	1M	351.18K
Effective Tax Rate %	0.55%	0.86%	0.83%	0.85%	0.83%	0.83%	0.56%
Net Income+	223.38K	2.57M	3.03M	4.59M	6.24M	4.6M	398.17K
Net Margin %	0.02%	0.16%	0.17%	0.18%	0.21%	0.16%	0.02%
Net Income Growth %	-	10.52%	0.18%	0.52%	0.36%	-0.26%	-0.91%
Net Income (Continuing)	223.38K	2.56M	3.1M	4.61M	6.24M	4.55M	364.76K
Discontinued Operations	0	0	0	0	0	0	-19.51K
Minority Interest	0	425K	506.73K	527.87K	530.49K	497.18K	442.85K
EPS (Diluted)+	0.43	4.98	5.80	170.00	185.75	125.00	0.17
EPS Growth %	-	10.58%	0.16%	28.31%	0.09%	-0.33%	-1%
EPS (Basic)	0.43	4.98	5.81	6.94	186.75	125.75	0.17
Diluted Shares Outstanding	516.67K	516.67K	521.07K	670.62K	839.61K	919.81K	2.4M
Basic Shares Outstanding	516.67K	516.67K	521.84K	675.12K	842.9K	919.2K	2.28M
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Total Current Assets+	13.45M	8.58M	10.84M	16.55M	14.72M	24.18M	39.79M
Cash & Short-Term Investments	820.86K	293.77K	53.11K	3.61M	840.86K	112.82K	80.47K
Cash Only	820.86K	293.77K	53.11K	1.9M	840.86K	112.75K	80.47K
Short-Term Investments	0	0	0	1.7M	0	65	0
Accounts Receivable	2.55M	5.24M	5.77M	6.15M	6.78M	4.6M	11.81M
Days Sales Outstanding	86.47	116.57	115.61	88.09	82.79	56.9	180.85
Inventory	9.4M	2.6M	1.02M	5.69M	1.72M	16.1M	1.57M
Days Inventory Outstanding	407.87	85.52	28.5	112.99	30.68	284.21	34.29
Other Current Assets	0	367.66K	501.08K	1M	277.51K	1.01M	11.86M
Total Non-Current Assets+	3.19M	10.98M	14.36M	19.86M	22.54M	22.37M	21.97M
Property, Plant & Equipment	3.01M	9.5M	14.17M	19.43M	22.17M	21.38M	15.15M
Fixed Asset Turnover	3.58x	1.73x	1.29x	1.31x	1.35x	1.38x	1.57x
Goodwill	0	0	0	0	0	0	0
Intangible Assets	147.97K	138.37K	140.99K	411.06K	366.17K	995.23K	777K
Long-Term Investments	-35.53K	0	-510.08K	0	22.54M	22.37M	0
Other Non-Current Assets	35.53K	1.31M	510.08K	0	-22.54M	-22.37M	6.05M
Total Assets+	16.64M	19.56M	25.2M	36.41M	37.26M	46.56M	61.77M
Asset Turnover	0.65x	0.84x	0.72x	0.70x	0.80x	0.63x	0.39x
Asset Growth %	-	0.18%	0.29%	0.44%	0.02%	0.25%	0.33%
Total Current Liabilities+	8.75M	10.86M	11.7M	7.53M	6.65M	9.61M	16.45M
Accounts Payable	2.72M	3.22M	1.29M	380.38K	214.59K	1.4M	3.43M
Days Payables Outstanding	118.21	105.78	36.13	7.55	3.82	24.79	74.77
Short-Term Debt	3.18M	4.3M	3.21M	734.49K	4.63M	2.93M	6.18M
Deferred Revenue (Current)	0	0	385.98K	1000K	188.75K	106.51K	506.77K
Other Current Liabilities	702.62K	2.74M	6.73M	1.69M	576.1K	2.8M	11.54K
Current Ratio	1.54x	0.79x	0.93x	2.20x	2.21x	2.52x	2.42x
Quick Ratio	0.46x	0.55x	0.84x	1.44x	1.95x	0.84x	2.32x
Cash Conversion Cycle	376.13	96.3	107.98	193.53	109.66	316.32	140.37
Total Non-Current Liabilities+	3.35M	1.43M	2.48M	2.35M	517.01K	963.09K	970.06K
Long-Term Debt	3.35M	1.4M	2.48M	2.17M	189.81K	871.37K	970.06K
Capital Lease Obligations	0	31.82K	0	175.66K	327.2K	91.72K	0
Deferred Tax Liabilities	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0
Total Liabilities	12.1M	12.3M	14.18M	9.88M	7.16M	10.57M	17.42M
Total Debt+	6.53M	6.09M	5.72M	3.31M	5.41M	4.12M	7.3M
Net Debt	5.71M	5.8M	5.67M	1.16M	4.57M	4.09M	7.22M
Debt / Equity	1.44x	0.84x	0.52x	0.12x	0.18x	0.11x	0.16x
Debt / EBITDA	7.91x	1.79x	1.55x	0.58x	0.78x	0.58x	2.32x
Net Debt / EBITDA	6.91x	1.71x	1.53x	0.20x	0.66x	0.58x	2.29x
Interest Coverage	2.10x	9.53x	10.54x	12.94x	14.64x	24.84x	6.18x
Total Equity+	4.55M	7.26M	11.02M	26.53M	30.09M	35.98M	44.35M
Equity Growth %	-	0.6%	0.52%	1.41%	0.13%	0.2%	0.23%
Book Value per Share	8.80	14.06	21.15	39.57	35.84	39.12	18.46
Total Shareholders' Equity	4.55M	6.84M	10.52M	26.01M	29.56M	35.48M	43.91M
Common Stock	517	517	580	833	840	1.17K	3.97K
Retained Earnings	52.12K	2.37M	5.07M	9.19M	14.68M	18.7M	18.74M
Treasury Stock	0	0	0	0	0	0	0
Accumulated OCI	-546.35K	-570.83K	191.82K	1.27M	-827.05K	-1.31M	155.94K
Minority Interest	0	425K	506.73K	527.87K	530.49K	497.18K	442.85K

Cash Flow

	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Cash from Operations+	273.9K	7.1M	2.64M	4.05M	-187.12K	-651.91K	-7.72M
Operating CF Margin %	0.03%	0.43%	0.15%	0.16%	-0.01%	-0.02%	-0.32%
Operating CF Growth %	-	24.94%	-0.63%	0.53%	-1.05%	-2.48%	-10.85%
Net Income	223.38K	2.56M	3.1M	4.61M	6.24M	4.57M	364.76K
Depreciation & Amortization	224.08K	226.63K	230.6K	286.69K	369.5K	1.18M	1.28M
Stock-Based Compensation	0	0	0	44.91K	170.88K	131.09K	1.32M
Deferred Taxes	61.48K	-5.15K	-7.75K	29.11K	19.01K	1.41K	0
Other Non-Cash Items	275.67K	0	31.77K	-264.46K	-157.79K	159.6K	985.27K
Working Capital Changes	-510.72K	4.29M	-709.86K	-652.58K	-6.83M	-6.7M	-11.67M
Change in Receivables	-145.38K	-2.91M	-284.55K	-89.54K	-1.3M	2.08M	-6.81M
Change in Inventory	452.85K	6.68M	1.64M	-209.01K	-157.71K	721.37K	-530.64K
Change in Payables	-1.12M	-78.36K	-1.98M	-969.41K	-141.93K	833.55K	1.92M
Cash from Investing+	-1.68M	-8.43M	-3M	-7.44M	-3.06M	-1.19M	-15.73K
Capital Expenditures	-1.68M	-7.07M	-4.33M	-4.75M	-4.74M	-522.03K	-7.05K
CapEx % of Revenue	0.16%	0.43%	0.24%	0.19%	0.16%	0.02%	0%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	0	-1.79M	0	3.7M	-4.71M	-663.57K	-8.74K
Cash from Financing+	2.02M	804.68K	112.49K	5.35M	2.26M	1.16M	8.76M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	0	435.96K	-281.55K	-521.65K	0	3.06K	5K
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	-1.41M	29.93K	-1.69M	-700.78K	-4.92M	-713.82K	-7.73M
FCF Margin %	-0.13%	0%	-0.09%	-0.03%	-0.16%	-0.02%	-0.32%
FCF Growth %	-	1.02%	-57.46%	0.59%	-6.02%	0.86%	-9.83%
FCF per Share	-2.73	0.06	-3.24	-1.04	-5.86	-0.78	-3.22
FCF Conversion (FCF/Net Income)	1.23x	2.76x	0.87x	0.88x	-0.03x	-0.14x	-19.40x
Interest Paid	286.46K	333.19K	0	417.27K	446.88K	238.22K	303.32K
Taxes Paid	336.39K	115.18K	0	2.41K	2.29M	478.68K	0

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	4.91%	43.59%	33.1%	24.45%	22.03%	13.91%	0.99%
Return on Invested Capital (ROIC)	4.4%	20.42%	17.48%	18.15%	15.67%	11.89%	3.07%
Gross Margin	22.01%	32.22%	28.55%	27.9%	31.51%	29.94%	29.82%
Net Margin	2.07%	15.7%	16.61%	18.01%	20.86%	15.57%	1.67%
Debt / Equity	1.44x	0.84x	0.52x	0.12x	0.18x	0.11x	0.16x
Interest Coverage	2.10x	9.53x	10.54x	12.94x	14.64x	24.84x	6.18x
FCF Conversion	1.23x	2.76x	0.87x	0.88x	-0.03x	-0.14x	-19.40x
Revenue Growth	-	52.07%	11.12%	39.93%	17.31%	-1.29%	-19.23%

Revenue by Geography

	2023	2024
Overseas	551.24K	301.69K
Overseas Growth	-	-45.27%

Frequently Asked Questions

Valuation & Price

Bon Natural Life Limited (BON) has a price-to-earnings (P/E) ratio of 10.2x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Bon Natural Life Limited (BON) reported $47.2M in revenue for fiscal year 2024. This represents a 337% increase from $10.8M in 2018.

Bon Natural Life Limited (BON) saw revenue decline by 19.2% over the past year.

Yes, Bon Natural Life Limited (BON) is profitable, generating $3.0M in net income for fiscal year 2024 (1.7% net margin).

Dividend & Returns

Bon Natural Life Limited (BON) has a return on equity (ROE) of 1.0%. This is below average, suggesting room for improvement.

Bon Natural Life Limited (BON) had negative free cash flow of $11.0M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Bon Natural Life Limited (BON) 10-Year Financial Performance & Capital Metrics

BON • • Industrial / General

Consumer DefensivePackaged FoodsNutritional Supplements & WellnessHerbal & Natural Health Products

Revenue $24M -19.2%
EBITDA $3M -55.6%
Net Income $398K -91.3%
EPS (Diluted) 0.17 -99.9%
Gross Margin 29.82% -0.4%
EBITDA Margin 13.21% -45.1%
Operating Margin 7.86% -60.8%
Net Margin 1.67% -89.3%
ROE 0.99% -92.9%
ROIC 3.07% -74.2%
Debt/Equity 0.16 +43.8%
Interest Coverage 6.18 -75.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Healthy 5Y average net margin of 14.5%
✓Trading at only 0.1x book value

✗Weaknesses

✗Profits declining 31.2% over 5 years
✗Weak Piotroski F-Score: 1/9
✗Negative free cash flow
✗Shares diluted 100.0% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y7.78%

3Y-2.21%

TTM-18.47%

Profit (Net Income) CAGR

10Y-

5Y-31.15%

3Y-55.73%

TTM-71.39%

EPS CAGR

10Y-

5Y-49.11%

3Y-90%

TTM-74.09%

ROCE

10Y Avg20.96%

5Y Avg20.16%

3Y Avg14.69%

Latest4.55%

Peer Comparison

Herbal & Natural Health Products

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NATRNature's Sunshine Products, Inc.	396.1M	22.64	56.60	2.03%	3.18%	9.05%	3.62%	0.09
BONBon Natural Life Limited	10.59M	1.74	10.24	-19.23%	6.45%	5.65%		0.16
PAVSParanovus Entertainment Technology Ltd.	1.34M	2.01	-25.77	-98.91%	-272.35%	-62.13%		0.08

Profit & Loss

	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Sales/Revenue+	10.78M	16.4M	18.22M	25.49M	29.91M	29.52M	23.84M
Revenue Growth %	-	0.52%	0.11%	0.4%	0.17%	-0.01%	-0.19%
Cost of Goods Sold+	8.41M	11.11M	13.02M	18.38M	20.48M	20.68M	16.73M
COGS % of Revenue	0.78%	0.68%	0.71%	0.72%	0.68%	0.7%	0.7%
Gross Profit+	2.37M	5.28M	5.2M	7.11M	9.42M	8.84M	7.11M
Gross Margin %	0.22%	0.32%	0.29%	0.28%	0.32%	0.3%	0.3%
Gross Profit Growth %	-	1.23%	-0.02%	0.37%	0.33%	-0.06%	-0.2%
Operating Expenses+	1.7M	1.97M	1.37M	1.71M	2.88M	2.92M	5.24M
OpEx % of Revenue	0.16%	0.12%	0.08%	0.07%	0.1%	0.1%	0.22%
Selling, General & Admin	1.21M	1.58M	1.53M	1.46M	2.46M	2.62M	3.62M
SG&A % of Revenue	0.11%	0.1%	0.08%	0.06%	0.08%	0.09%	0.15%
Research & Development	556.09K	522.87K	205.36K	249.05K	424.56K	298.47K	1.62M
R&D % of Revenue	0.05%	0.03%	0.01%	0.01%	0.01%	0.01%	0.07%
Other Operating Expenses	0	0	-362.19K	0	0	0	0
Operating Income+	602.14K	3.18M	3.47M	5.4M	6.54M	5.92M	1.87M
Operating Margin %	0.06%	0.19%	0.19%	0.21%	0.22%	0.2%	0.08%
Operating Income Growth %	-	4.27%	0.09%	0.56%	0.21%	-0.1%	-0.68%
EBITDA+	826.23K	3.4M	3.7M	5.69M	6.91M	7.1M	3.15M
EBITDA Margin %	0.08%	0.21%	0.2%	0.22%	0.23%	0.24%	0.13%
EBITDA Growth %	-	3.12%	0.09%	0.54%	0.21%	0.03%	-0.56%
D&A (Non-Cash Add-back)	224.08K	226.63K	230.6K	286.69K	369.5K	1.18M	1.28M
EBIT	692.12K	3.32M	3.47M	5.85M	7.96M	5.79M	1.02M
Net Interest Income+	-285.22K	-330.92K	-328.39K	-414.06K	-445.49K	-228.81K	-302.86K
Interest Income	1.24K	2.27K	714	3.21K	1.39K	9.42K	393
Interest Expense	286.46K	333.19K	329.1K	417.27K	446.88K	238.22K	303.25K
Other Income/Expense	-196.49K	-185.34K	186.41K	29.76K	969.23K	-363.66K	-1.16M
Pretax Income+	405.65K	2.99M	3.65M	5.43M	7.51M	5.55M	715.94K
Pretax Margin %	0.04%	0.18%	0.2%	0.21%	0.25%	0.19%	0.03%
Income Tax+	182.28K	427.19K	556.26K	820.93K	1.27M	1M	351.18K
Effective Tax Rate %	0.55%	0.86%	0.83%	0.85%	0.83%	0.83%	0.56%
Net Income+	223.38K	2.57M	3.03M	4.59M	6.24M	4.6M	398.17K
Net Margin %	0.02%	0.16%	0.17%	0.18%	0.21%	0.16%	0.02%
Net Income Growth %	-	10.52%	0.18%	0.52%	0.36%	-0.26%	-0.91%
Net Income (Continuing)	223.38K	2.56M	3.1M	4.61M	6.24M	4.55M	364.76K
Discontinued Operations	0	0	0	0	0	0	-19.51K
Minority Interest	0	425K	506.73K	527.87K	530.49K	497.18K	442.85K
EPS (Diluted)+	0.43	4.98	5.80	170.00	185.75	125.00	0.17
EPS Growth %	-	10.58%	0.16%	28.31%	0.09%	-0.33%	-1%
EPS (Basic)	0.43	4.98	5.81	6.94	186.75	125.75	0.17
Diluted Shares Outstanding	516.67K	516.67K	521.07K	670.62K	839.61K	919.81K	2.4M
Basic Shares Outstanding	516.67K	516.67K	521.84K	675.12K	842.9K	919.2K	2.28M
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Total Current Assets+	13.45M	8.58M	10.84M	16.55M	14.72M	24.18M	39.79M
Cash & Short-Term Investments	820.86K	293.77K	53.11K	3.61M	840.86K	112.82K	80.47K
Cash Only	820.86K	293.77K	53.11K	1.9M	840.86K	112.75K	80.47K
Short-Term Investments	0	0	0	1.7M	0	65	0
Accounts Receivable	2.55M	5.24M	5.77M	6.15M	6.78M	4.6M	11.81M
Days Sales Outstanding	86.47	116.57	115.61	88.09	82.79	56.9	180.85
Inventory	9.4M	2.6M	1.02M	5.69M	1.72M	16.1M	1.57M
Days Inventory Outstanding	407.87	85.52	28.5	112.99	30.68	284.21	34.29
Other Current Assets	0	367.66K	501.08K	1M	277.51K	1.01M	11.86M
Total Non-Current Assets+	3.19M	10.98M	14.36M	19.86M	22.54M	22.37M	21.97M
Property, Plant & Equipment	3.01M	9.5M	14.17M	19.43M	22.17M	21.38M	15.15M
Fixed Asset Turnover	3.58x	1.73x	1.29x	1.31x	1.35x	1.38x	1.57x
Goodwill	0	0	0	0	0	0	0
Intangible Assets	147.97K	138.37K	140.99K	411.06K	366.17K	995.23K	777K
Long-Term Investments	-35.53K	0	-510.08K	0	22.54M	22.37M	0
Other Non-Current Assets	35.53K	1.31M	510.08K	0	-22.54M	-22.37M	6.05M
Total Assets+	16.64M	19.56M	25.2M	36.41M	37.26M	46.56M	61.77M
Asset Turnover	0.65x	0.84x	0.72x	0.70x	0.80x	0.63x	0.39x
Asset Growth %	-	0.18%	0.29%	0.44%	0.02%	0.25%	0.33%
Total Current Liabilities+	8.75M	10.86M	11.7M	7.53M	6.65M	9.61M	16.45M
Accounts Payable	2.72M	3.22M	1.29M	380.38K	214.59K	1.4M	3.43M
Days Payables Outstanding	118.21	105.78	36.13	7.55	3.82	24.79	74.77
Short-Term Debt	3.18M	4.3M	3.21M	734.49K	4.63M	2.93M	6.18M
Deferred Revenue (Current)	0	0	385.98K	1000K	188.75K	106.51K	506.77K
Other Current Liabilities	702.62K	2.74M	6.73M	1.69M	576.1K	2.8M	11.54K
Current Ratio	1.54x	0.79x	0.93x	2.20x	2.21x	2.52x	2.42x
Quick Ratio	0.46x	0.55x	0.84x	1.44x	1.95x	0.84x	2.32x
Cash Conversion Cycle	376.13	96.3	107.98	193.53	109.66	316.32	140.37
Total Non-Current Liabilities+	3.35M	1.43M	2.48M	2.35M	517.01K	963.09K	970.06K
Long-Term Debt	3.35M	1.4M	2.48M	2.17M	189.81K	871.37K	970.06K
Capital Lease Obligations	0	31.82K	0	175.66K	327.2K	91.72K	0
Deferred Tax Liabilities	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0
Total Liabilities	12.1M	12.3M	14.18M	9.88M	7.16M	10.57M	17.42M
Total Debt+	6.53M	6.09M	5.72M	3.31M	5.41M	4.12M	7.3M
Net Debt	5.71M	5.8M	5.67M	1.16M	4.57M	4.09M	7.22M
Debt / Equity	1.44x	0.84x	0.52x	0.12x	0.18x	0.11x	0.16x
Debt / EBITDA	7.91x	1.79x	1.55x	0.58x	0.78x	0.58x	2.32x
Net Debt / EBITDA	6.91x	1.71x	1.53x	0.20x	0.66x	0.58x	2.29x
Interest Coverage	2.10x	9.53x	10.54x	12.94x	14.64x	24.84x	6.18x
Total Equity+	4.55M	7.26M	11.02M	26.53M	30.09M	35.98M	44.35M
Equity Growth %	-	0.6%	0.52%	1.41%	0.13%	0.2%	0.23%
Book Value per Share	8.80	14.06	21.15	39.57	35.84	39.12	18.46
Total Shareholders' Equity	4.55M	6.84M	10.52M	26.01M	29.56M	35.48M	43.91M
Common Stock	517	517	580	833	840	1.17K	3.97K
Retained Earnings	52.12K	2.37M	5.07M	9.19M	14.68M	18.7M	18.74M
Treasury Stock	0	0	0	0	0	0	0
Accumulated OCI	-546.35K	-570.83K	191.82K	1.27M	-827.05K	-1.31M	155.94K
Minority Interest	0	425K	506.73K	527.87K	530.49K	497.18K	442.85K

Cash Flow

	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Cash from Operations+	273.9K	7.1M	2.64M	4.05M	-187.12K	-651.91K	-7.72M
Operating CF Margin %	0.03%	0.43%	0.15%	0.16%	-0.01%	-0.02%	-0.32%
Operating CF Growth %	-	24.94%	-0.63%	0.53%	-1.05%	-2.48%	-10.85%
Net Income	223.38K	2.56M	3.1M	4.61M	6.24M	4.57M	364.76K
Depreciation & Amortization	224.08K	226.63K	230.6K	286.69K	369.5K	1.18M	1.28M
Stock-Based Compensation	0	0	0	44.91K	170.88K	131.09K	1.32M
Deferred Taxes	61.48K	-5.15K	-7.75K	29.11K	19.01K	1.41K	0
Other Non-Cash Items	275.67K	0	31.77K	-264.46K	-157.79K	159.6K	985.27K
Working Capital Changes	-510.72K	4.29M	-709.86K	-652.58K	-6.83M	-6.7M	-11.67M
Change in Receivables	-145.38K	-2.91M	-284.55K	-89.54K	-1.3M	2.08M	-6.81M
Change in Inventory	452.85K	6.68M	1.64M	-209.01K	-157.71K	721.37K	-530.64K
Change in Payables	-1.12M	-78.36K	-1.98M	-969.41K	-141.93K	833.55K	1.92M
Cash from Investing+	-1.68M	-8.43M	-3M	-7.44M	-3.06M	-1.19M	-15.73K
Capital Expenditures	-1.68M	-7.07M	-4.33M	-4.75M	-4.74M	-522.03K	-7.05K
CapEx % of Revenue	0.16%	0.43%	0.24%	0.19%	0.16%	0.02%	0%
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	0	-1.79M	0	3.7M	-4.71M	-663.57K	-8.74K
Cash from Financing+	2.02M	804.68K	112.49K	5.35M	2.26M	1.16M	8.76M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	0	435.96K	-281.55K	-521.65K	0	3.06K	5K
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	-1.41M	29.93K	-1.69M	-700.78K	-4.92M	-713.82K	-7.73M
FCF Margin %	-0.13%	0%	-0.09%	-0.03%	-0.16%	-0.02%	-0.32%
FCF Growth %	-	1.02%	-57.46%	0.59%	-6.02%	0.86%	-9.83%
FCF per Share	-2.73	0.06	-3.24	-1.04	-5.86	-0.78	-3.22
FCF Conversion (FCF/Net Income)	1.23x	2.76x	0.87x	0.88x	-0.03x	-0.14x	-19.40x
Interest Paid	286.46K	333.19K	0	417.27K	446.88K	238.22K	303.32K
Taxes Paid	336.39K	115.18K	0	2.41K	2.29M	478.68K	0

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	4.91%	43.59%	33.1%	24.45%	22.03%	13.91%	0.99%
Return on Invested Capital (ROIC)	4.4%	20.42%	17.48%	18.15%	15.67%	11.89%	3.07%
Gross Margin	22.01%	32.22%	28.55%	27.9%	31.51%	29.94%	29.82%
Net Margin	2.07%	15.7%	16.61%	18.01%	20.86%	15.57%	1.67%
Debt / Equity	1.44x	0.84x	0.52x	0.12x	0.18x	0.11x	0.16x
Interest Coverage	2.10x	9.53x	10.54x	12.94x	14.64x	24.84x	6.18x
FCF Conversion	1.23x	2.76x	0.87x	0.88x	-0.03x	-0.14x	-19.40x
Revenue Growth	-	52.07%	11.12%	39.93%	17.31%	-1.29%	-19.23%

Revenue by Geography

	2023	2024
Overseas	551.24K	301.69K
Overseas Growth	-	-45.27%

Frequently Asked Questions

Valuation & Price

Bon Natural Life Limited (BON) has a price-to-earnings (P/E) ratio of 10.2x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Bon Natural Life Limited (BON) reported $47.2M in revenue for fiscal year 2024. This represents a 337% increase from $10.8M in 2018.

Bon Natural Life Limited (BON) saw revenue decline by 19.2% over the past year.

Yes, Bon Natural Life Limited (BON) is profitable, generating $3.0M in net income for fiscal year 2024 (1.7% net margin).

Dividend & Returns

Bon Natural Life Limited (BON) has a return on equity (ROE) of 1.0%. This is below average, suggesting room for improvement.

Bon Natural Life Limited (BON) had negative free cash flow of $11.0M in fiscal year 2024, likely due to heavy capital investments.